Agilent Technologies, Inc. A

SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.

Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...

Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.

Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-free Array Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2

AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-Free Detection - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4

SANTA CLARA, Calif., September 21, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequenci

On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]

SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte

Opportunities span advanced MRI, particle accelerators, fusion energy, mass spectrometry, quantum computing and transportation. Better superconducting materials and cooling can cut operating costs, while supply-chain shifts open new sourcing options.Dublin, Sept. 11, 2026 (GLOBE NEWSWIRE) -- "Superconducting Magnets - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Superconducting Magnets was valued at US$3.9 Billion in 2024 and is proj

SANTA CLARA, Calif., September 10, 2026--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m. BST on Wednesday, Sept. 23, 2026, in London. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.

Outpacing the Dow over the past 12 months, Agilent Technologies continues to receive a moderately bullish outlook from Wall Street analysts.

The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker development, single-cell and spatial transcriptomics, long-read RNA sequencing, and AI-powered analytics. Consumables, bulk RNA-seq, drug discovery applications, and pharmaceutical and biotechnology companies led the market in 2025. North America held the largest regional share